Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.

@article{Nozawa1997SolubleF,
  title={Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.},
  author={Kazuhisa Nozawa and Nobuhiko Kayagaki and Yoshiaki Tokano and H. Yagita and Ko Okumura and Hiromi Hasimoto},
  journal={Arthritis and rheumatism},
  year={1997},
  volume={40 6},
  pages={1126-9}
}
OBJECTIVE To assess levels of soluble Fas (sFas) and soluble Fas ligand (sFas-L) in sera from patients with various rheumatic diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), polymyositis/dermatomyositis (PM/DM), mixed connective tissue disease (MCTD), and Sjogren's syndrome (SS). METHODS Levels of sFas and sFas-L were determined by a sandwich enzyme-linked immunosorbent assay. RESULTS In SLE, PM/DM, MCTD, and SS, sFas levels were… CONTINUE READING
44 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 44 extracted citations

Similar Papers

Loading similar papers…